Segment Information (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Summary of Net sales and Operating Profit by Segment

Net sales and operating profit by segment are as follows (in millions):

	Net Sales				Operating (Loss) Profit
	Three Months Ended				Three Months Ended
	June 30,				June 30,
	2020		2019		2020			2019
Americas and Global Businesses	$	757.5	$	1,255.1	$	83.0		$	427.2
EMEA		204.1		405.8		20.0			117.5
Asia Pacific		264.5		327.7		78.4			118.0
Corporate Functions		-		-		(111.6	)		(117.5	)
Total	$	1,226.1	$	1,988.6
Inventory and manufacturing-related charges						(1.4	)		(34.1	)
Intangible asset amortization						(147.7	)		(146.9	)
Intangible asset impairment						(33.0	)		(70.1	)
Restructuring and other cost reduction initiatives						(28.0	)		(6.9	)
Quality remediation						(9.9	)		(23.4	)
Acquisition, integration and related						(2.2	)		(5.1	)
Litigation						(1.3	)		(7.0	)
European Union Medical Device Regulation						(6.1	)		(5.1	)
Other charges						(11.9	)		(41.9	)
Operating (loss) profit					$	(171.7	)	$	204.7

	Net Sales				Operating (Loss) Profit
	Six Months Ended				Six Months Ended
	June 30,				June 30,
	2020		2019		2020			2019
Americas and Global Businesses	$	1,894.1	$	2,490.7	$	451.8		$	817.2
EMEA		575.4		834.7		128.8			256.7
Asia Pacific		540.4		638.7		171.0			231.5
Corporate Functions		-		-		(215.6	)		(235.2	)
Total	$	3,009.9	$	3,964.1
Inventory and manufacturing-related charges						(2.0	)		(36.1	)
Intangible asset amortization						(295.3	)		(290.3	)
Goodwill and intangible asset impairment						(645.0	)		(70.1	)
Restructuring and other cost reduction initiatives						(73.0	)		(11.6	)
Quality remediation						(25.8	)		(43.1	)
Acquisition, integration and related						(6.6	)		(11.1	)
Litigation						(81.1	)		(5.2	)
Litigation settlement gain						-			23.5
European Union Medical Device Regulation						(17.1	)		(6.7	)
Other charges						(17.8	)		(64.6	)
Operating (loss) profit					$	(627.7	)	$	554.9